country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-181113

Copy Link Print Information

ALK-IN-34

ALK-IN-34 is an Anaplastic Lymphoma Kinase (ALK) inhibitor with an IC₅₀ of 0.26 μM. ALK-IN-34 demonstrates antiproliferative activity against lung cancer cells and gastric adenocarcinoma cells.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

화학식: C₂₅H₂₁N₃O
분자량:379.45

보관:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (277 KB)

ALK-IN-34 Chemical Structure

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- In Vitro
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

In Vitro

ALK-IN-34 (compound 8c) (1-100 μM; 72 h) potently inhibits proliferation of Karpas 299 cells (IC₅₀ = 2.17 μM) and H2228 cells (IC₅₀ = 6.02 μM), with lower potency against A549 and AGS cells^[1].
ALK-IN-34 (10 μM) shows greater selectivity towards ALK but also significantly inhibits EGFR and VEGFR2 kinases at 10 μM^[1].
ALK-IN-34 has lower toxicity towards L929 normal cells (IC₅₀ = 102.2 μM) compared to Karpas 299 cancer cells, with a selectivity index of 47.09^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:

Karpas 299 (NPM-ALK-positive ALCL), H2228 (EML4-ALK-positive NSCLC), A549 (ALK-negative NSCLC), AGS (gastric adenocarcinoma)
Concentration:

1, 5, 10, 25, 50, 100 μM
Incubation Time:

72 h
Result:

Inhibited proliferation of Karpas 299 cells with an IC₅₀ of 2.17 μM, H2228 cells with an IC₅₀ of 6.02 μM, A549 cells with an IC₅₀ of 41 μM, and AGS cells with an IC₅₀ of 45.8 μM.

Chemical Information

분자량 379.45
화학식 C₂₅H₂₁N₃O
SMILES

COC(C=C1)=CC=C1C2=C3C(C4=CC=CC=C4CC3)=NC(NC5=CC=CC=C5)=N2
선적

Room temperature in continental US; may vary elsewhere.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Saravanakumar N, et al. Combined in silico and in vitro cytotoxic profiling of novel quinazoline derivatives targeting anaplastic lymphoma kinase for lung cancer therapy. Bioorg Chem. 2026;170:109450. [Content Brief]

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

견적 받기 해외재고보유